Gerber Products Company logo, baby food and baby product brand, graphic element on white via Associated Press
Contamination concerns have forced Gerber to pull some of its baby formula from store shelves.
Gerber parent company Perrigo issued a voluntary recall of Gerber's Good Start SoothePro Infant Formula "out of an abundance of caution" regarding a link to possible Cronobacter sakazakii contamination.
The impacted products were manufactured in Eau Claire, Wisconsin between January 2 and January 18.
"Importantly, no distributed product has tested positive for the presence of this bacteria, no adverse events have been reported and no other products manufactured at this facility or any other of Perrigo's facilities are affected by this recall," the company said in a statement.
Cronobacter sakazakii is a bacteria that is relatively common and typically does not impact most people, but when newborns and infants with compromised immune systems are exposed, it can potentially cause sepsis and meningitis, according to the Centers for Disease Control and Prevention.
"Every batch of infant formula is tested to make certain it meets stringent nutritional, safety, quality and regulatory requirements," Perrigo Company stated.
The recall comes just a month after an Enfamil baby formula recall due to concerns over the same kind of contamination.
Wearable robotics are moving beyond sci-fi. Dephy CEO Luke Mooney explains how its smart ankle exoskeleton is changing mobility, recovery and everyday movement.
Voice AI is moving into cars, restaurants and customer service. SoundHound CEO Keyvan Mohajer explains the company’s growth and the future of voice-powered AI.
Americans are still spending, but rising anxiety over jobs, AI, housing and tariffs tells a different story. Kearney Consumer Institute’s Katie Thomas explains.
Disney is back in focus after Q3 earnings. Investors are watching streaming profits, theme parks and ESPN as the entertainment giant looks for its next catalyst
Healthcare policy is shifting fast, raising questions about drug prices, Medicare and access. Leap Health CEO Hani Elias explains what patients need to know.
The U.S. job market is cooling as hiring slows and employers turn cautious. LinkedIn’s Kory Kantenga breaks down jobs, wages, spending and AI’s impact.
AI is entering a new phase as enterprises move beyond experimentation and demand measurable returns. Appian CEO Matt Calkins discusses what comes next.
Commercial Metals CEO Peter Matt reveals how a $2.5B acquisition spree is transforming the 111-year-old steelmaker into a construction solutions powerhouse.